PubMed

Lean-Agile Product Development in FDA Relevant and Regulated Medical Device Contexts.

PMID：42745015 · 2026-09-15

A, l, l, i, y, , A, d, e, w, a, l, e, , B, e, l, l, o, ;, , K, e, l, v, i, n, , E, b, o, , R, a, b, b, l, e, s, ;, , V, i, c, t, o, r, , O, s, e, m, u, d, i, a, m, e, ;, , B, e, n, n, y, , U, h, o, r, a, n, i, s, h, e, m, a

期刊Therapeutic innovation & regulatory science

年份2026-09-15

PMID42745015

摘要

This scoping review examines the implementation of Lean, Agile and hybrid Lean-Agile approaches in contexts relevant to the US Food and Drug Administration (FDA) and regulated medical devices. The review assesses whether these approaches can facilitate faster development while ensuring the integrity of lifecycle evidence, regulatory compliance and safety. The focus is on digital QMS, documentation, validation, design controls, and critical adoption barriers and enablers. A PRISMA-ScR aligned sco

官方來源

在 PubMed 上查看 →

資料來自 PubMed / NCBI。全文與最新資訊請一律參閱官方紀錄。